中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Reversion of Multidrug-Resistance by Proteasome Inhibitor Bortezomib in K562/DNR Cell Line

文献类型:期刊论文

作者Wang Huihan; Li Yingchun; Liao Aijun; Fu Beibei; Yang Wei; Liu Zhuogang; Wang Xiaobin
刊名CHINESE JOURNAL OF CANCER RESEARCH
出版日期2011
卷号23期号:1页码:69-73
关键词MULTIPLE-MYELOMA CELLS FACTOR-KAPPA-B CHEMOTHERAPEUTIC-AGENTS THERAPEUTIC TARGET DRUG-RESISTANCE P-GLYCOPROTEIN LEUKEMIA CANCER MALIGNANCIES SENSITIVITY Bortezomib NF-kappa B Multi-drug resistance mdr1 gene P-gp K562 cells
ISSN号1000-9604
其他题名Reversion of Multidrug-Resistance by Proteasome Inhibitor Bortezomib in K562/DNR Cell Line
英文摘要Objective: To observe the reversion of multi-drug resistance by proteasome inhibitor bortezomib in K562/DNR cell line and to analyze the possible mechanism of reversion of multidrug-resistance.
资助项目[Educational Commission of Liaoning Province, China]
语种英语
CSCD记录号CSCD:4173900
源URL[http://ir.imr.ac.cn/handle/321006/156095]  
专题金属研究所_中国科学院金属研究所
作者单位中国科学院金属研究所
推荐引用方式
GB/T 7714
Wang Huihan,Li Yingchun,Liao Aijun,et al. Reversion of Multidrug-Resistance by Proteasome Inhibitor Bortezomib in K562/DNR Cell Line[J]. CHINESE JOURNAL OF CANCER RESEARCH,2011,23(1):69-73.
APA Wang Huihan.,Li Yingchun.,Liao Aijun.,Fu Beibei.,Yang Wei.,...&Wang Xiaobin.(2011).Reversion of Multidrug-Resistance by Proteasome Inhibitor Bortezomib in K562/DNR Cell Line.CHINESE JOURNAL OF CANCER RESEARCH,23(1),69-73.
MLA Wang Huihan,et al."Reversion of Multidrug-Resistance by Proteasome Inhibitor Bortezomib in K562/DNR Cell Line".CHINESE JOURNAL OF CANCER RESEARCH 23.1(2011):69-73.

入库方式: OAI收割

来源:金属研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。